Lone Star Oncology Consultants

Austin, Texas 78759

0 studies enrolling now · 3 studies all time

What they study most

NSCLC, Non-Small Cell Lung Cancer, Prostate Cancer

Studies at this site

• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL — Withdrawn before enrolling
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early